CNMD - conmed.com PEG Multiple

Symbol and logo of brand conmed.com (CNMD)

CONMED Corporation maintains a stable financial position, with operating cash flow fully covering capital expenditures. The valuation-to-growth adequacy ratio on the GURU.Markets daily chart reflects current trends, where 2.41 expresses the latest metric level. Regular sales of consumables ensure cash flow stability, although government budget cuts and logistics costs create certain risks for margins.

CNMD - CONMED Corp. PEG Multiple over the range 07/04/2022 - 11/15/2026

CONMED (CNMD) - metric breakdowns and financial figures

- current quotes and average value forecast:
Market Price CONMED Corporation|CNMD - Consensus Target
- market capitalization statistics:
Market Capitalization CONMED Corporation|CNMD - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Price of a Share CONMED|CNMD - Book Capitalization|Market Capitalization to Book Value conmed.com|CNMD - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio CONMED Corporation|CNMD - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CONMED Corp|CNMD - Company Debts|Debt to Book Value CONMED Inc.|CNMD - Company Long-Term Debts|Short-Term Debt CONMED|Immediate Liquidity Ratio conmed.com
- earnings and market ratios statistics:
CNMD - Net Profit|Company Profit Forecast CONMED Corporation|CNMD - P/E Multiple|Projected Price to Earnings CONMED Corporation|CNMD - PEG Multiple|EV/EBITDA Multiple CONMED|CNMD - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months CONMED|CNMD - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months conmed.com|CNMD - Earnings growth in current year|Expected net earnings per share growth next year CONMED Corporation
- issuer revenue and sales details:
CNMD - Company Revenue|Company Sales Forecast CONMED Corporation|CNMD - Market Cap to Revenue|Forward P/S Multiple CONMED Inc.
Fundamental company analysis:CNMD (CONMED Corp.)
Original product of conmed.com

In fundamental analysis, the PEG ratio compares earnings valuation to growth rates, where a value below one signals that an asset is undervalued. Analyzing this PEG chart, an investor can see the scaling efficiency of CONMED Corporation (CNMD), supported by management's expertise in launching technological innovations and strict supply chain control, which minimizes risks during the expansion of surgical equipment.

Competing companies

DXCM - Price to Earnings Adjusted for Growth Rate|Penumbra Corp - Price/Earnings to Growth Multiple|PEG Multiple Novanta NOVT|Haemonetics Corp - PEG Multiple|Inspire Medical Systems, Inc. - Company Value to Earnings Growth Ratio|PRCT: PEG Multiple|PLSE - Growth-Adjusted Market Cap to Net Income|INMD (inmodemd.com) - PEG Multiple|PMI: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple SRDX (Surmodics)|SENS (Senseonics Corp) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio NeuroPace Medical NPCE|TCMD - Price/Earnings to Growth Multiple|SANUWAVE Health - PEG Multiple|Growth-Adjusted Market Cap to Net Income Outset Medical, Inc. OM|ELMD: PEG Multiple|Growth-Adjusted P/E Ratio LNSR|RCEL (AVITA Medical Inc) - PEG Multiple|Profound Medical Corp. (PROF) - Growth-Adjusted Market Cap to Net Income|PEG Multiple BDMD|Price/Earnings to Growth Multiple EDAP TMS EDAP|PEG Multiple APYX (Apyx Medical Corp)|PEG Multiple IceCure Medical Ltd ICCM|LUNG - Price/Earnings to Growth Ratio|TELA: Price/Earnings to Growth Ratio|CTSO (CytoSorbents Corp.) - Price/Earnings to Growth Multiple|Sensus Healthcare, Inc. - Growth-Adjusted Payback Ratio|ZYXI (Zynex Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate electrocore.com ECOR|Price/Earnings to Growth Ratio Vicarious Surgical (RBOT)|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Price to Net Income Growth Ratio|PEG Multiple ICU (seastarmedical.com)|PEG Multiple IRIDEX Corp. IRIX|Intelligent Bio Solutions Inc - PEG Multiple|Growth-Adjusted Market Cap to Net Income Beyond Air XAIR|Profusa (PFSA) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio SSKN (STRATA Skin)|Price/Earnings to Growth Ratio glucotrack.com|Price/Earnings to Growth Multiple NanoVibronix, Inc. (NAOV)|PEG Multiple VERO|NUWE - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Aethlon Medical AEMD|ASXC: Growth-Adjusted P/E Ratio|AVGR: Price/Earnings to Growth Multiple|BioSig Technologies, Inc. - Company Value to Earnings Growth Ratio|CUTR: PEG Multiple|Growth-Adjusted P/E Ratio KNW|Price/Earnings to Growth Ratio Inari Medical, Inc.|Price to Earnings Adjusted for Growth Rate Nevro Corp. NVRO|Price/Earnings to Growth Ratio ReShape Lifesciences Inc (RSLS)|Price/Earnings to Growth Ratio SILK (silkroadmed.com)